E. Kelkitli Et Al. , "Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients.," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2013
Kelkitli, E. Et Al. 2013. Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients.. 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , (Illinois, United States Of America).
Kelkitli, E., Atay, M. H., Yıldız, L., & Turgut, M., (2013). Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients. . 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America
Kelkitli, Engin Et Al. "Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients.," 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 2013
Kelkitli, Engin Et Al. "Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients.." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America, 2013
Kelkitli, E. Et Al. (2013) . "Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients.." 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) , Illinois, United States Of America.
@conferencepaper{conferencepaper, author={Engin Kelkitli Et Al. }, title={Effect of LIM domain only (LMO2) protein expression on survival in multiple myeloma patients.}, congress name={49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)}, city={Illinois}, country={United States Of America}, year={2013}}